Position in LXRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$28,286
+$9,900 QoQ
Shares Held
11,786
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 148 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $1,902,676 across 11 Biotechnology names. LXRX ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAPR |
Capricor Therapeutics, Inc.
|
223,076 | $876,689 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
916 | $455,004 | |
| 3 | ABCL |
AbCellera Biologics Inc.
|
26,183 | $205,536 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292 | $182,073 | |
| 5 | DTIL |
Precision Biosciences Inc
|
10,164 | $79,889 | |
| 6 | LXRX |
Lexicon Pharmaceuticals, Inc.
This page
|
11,786 | $28,286 | |
| 7 | NMRA |
Neumora Therapeutics, Inc.
|
16,232 | $27,594 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
12,344 | $21,725 |
All Filings in LXRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,286 | 11,786 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $18,386 | 11,786 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $13,553 | 11,786 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $15,911 | 11,786 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $11,196 | 11,786 | Shares | Sole | 2025-08-04 | |
| No filing history on record for this holder in this stock. | ||||||